You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

PMB 400 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pmb 400 patents expire, and when can generic versions of Pmb 400 launch?

Pmb 400 is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in PMB 400 is estrogens, conjugated; meprobamate. There are three drug master file entries for this compound. Additional details are available on the estrogens, conjugated; meprobamate profile page.

Summary for PMB 400
Drug patent expirations by year for PMB 400
Anatomical Therapeutic Chemical (ATC) Classes for PMB 400

US Patents and Regulatory Information for PMB 400

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst PMB 400 estrogens, conjugated; meprobamate TABLET;ORAL 010971-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for PMB 400

See the table below for patents covering PMB 400 around the world.

Country Patent Number Title Estimated Expiration
Singapore 49715 Alkali metal 8,9-dehydroestrone sulfate esters ⤷  Try a Trial
Hungary T67553 ⤷  Try a Trial
Finland 115915 ⤷  Try a Trial
Japan 3715645 ⤷  Try a Trial
Spain 2274555 ⤷  Try a Trial
Finland 943903 ⤷  Try a Trial
Hong Kong 1011369 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.